UniProt ID | BABA1_HUMAN | |
---|---|---|
UniProt AC | Q9NWV8 | |
Protein Name | BRISC and BRCA1-A complex member 1 | |
Gene Name | BABAM1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 329 | |
Subcellular Localization | Cytoplasm . Nucleus . Localizes at sites of DNA damage at double-strand breaks (DSBs). | |
Protein Description | Component of the BRCA1-A complex, a complex that specifically recognizes 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA lesions sites, leading to target the BRCA1-BARD1 heterodimer to sites of DNA damage at double-strand breaks (DSBs). The BRCA1-A complex also possesses deubiquitinase activity that specifically removes 'Lys-63'-linked ubiquitin on histones H2A and H2AX. In the BRCA1-A complex, it is required for the complex integrity and its localization at DSBs. Component of the BRISC complex, a multiprotein complex that specifically cleaves 'Lys-63'-linked ubiquitin in various substrates. [PubMed: 24075985] | |
Protein Sequence | MEVAEPSSPTEEEEEEEEHSAEPRPRTRSNPEGAEDRAVGAQASVGSRSEGEGEAASADDGSLNTSGAGPKSWQVPPPAPEVQIRTPRVNCPEKVIICLDLSEEMSLPKLESFNGSKTNALNVSQKMIEMFVRTKHKIDKSHEFALVVVNDDTAWLSGLTSDPRELCSCLYDLETASCSTFNLEGLFSLIQQKTELPVTENVQTIPPPYVVRTILVYSRPPCQPQFSLTEPMKKMFQCPYFFFDVVYIHNGTEEKEEEMSWKDMFAFMGSLDTKGTSYKYEVALAGPALELHNCMAKLLAHPLQRPCQSHASYSLLEEEDEAIEVEATV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEVAEPSS -------CCCCCCCC | 9.37 | 19413330 | |
7 | Phosphorylation | -MEVAEPSSPTEEEE -CCCCCCCCCCHHHH | 40.22 | 29255136 | |
8 | Phosphorylation | MEVAEPSSPTEEEEE CCCCCCCCCCHHHHH | 46.70 | 29255136 | |
10 | Phosphorylation | VAEPSSPTEEEEEEE CCCCCCCCHHHHHHH | 58.96 | 29255136 | |
20 | Phosphorylation | EEEEEEHSAEPRPRT HHHHHHHCCCCCCCC | 37.29 | 22617229 | |
27 | Phosphorylation | SAEPRPRTRSNPEGA CCCCCCCCCCCCCCH | 40.92 | 23401153 | |
29 | Phosphorylation | EPRPRTRSNPEGAED CCCCCCCCCCCCHHH | 57.00 | 29255136 | |
37 | Methylation | NPEGAEDRAVGAQAS CCCCHHHHHHCCCCC | 23.76 | 115484531 | |
44 | Phosphorylation | RAVGAQASVGSRSEG HHHCCCCCCCCCCCC | 18.22 | 29255136 | |
46 (in isoform 2) | Phosphorylation | - | 18.17 | - | |
47 | Phosphorylation | GAQASVGSRSEGEGE CCCCCCCCCCCCCCC | 30.40 | 23401153 | |
48 (in isoform 2) | Ubiquitination | - | 32.57 | 21890473 | |
49 | Phosphorylation | QASVGSRSEGEGEAA CCCCCCCCCCCCCCC | 52.21 | 19664994 | |
57 | Phosphorylation | EGEGEAASADDGSLN CCCCCCCCCCCCCCC | 39.00 | 23927012 | |
62 | Phosphorylation | AASADDGSLNTSGAG CCCCCCCCCCCCCCC | 25.99 | 25159151 | |
65 | Phosphorylation | ADDGSLNTSGAGPKS CCCCCCCCCCCCCCC | 33.55 | 30278072 | |
66 | Phosphorylation | DDGSLNTSGAGPKSW CCCCCCCCCCCCCCC | 26.10 | 23927012 | |
71 | Ubiquitination | NTSGAGPKSWQVPPP CCCCCCCCCCCCCCC | 64.51 | - | |
72 | Phosphorylation | TSGAGPKSWQVPPPA CCCCCCCCCCCCCCC | 26.35 | 27251275 | |
86 | Phosphorylation | APEVQIRTPRVNCPE CCCCEEECCCCCCCC | 19.64 | - | |
112 | Phosphorylation | MSLPKLESFNGSKTN CCCCCHHHCCCCCCC | 34.15 | 23312004 | |
116 | Phosphorylation | KLESFNGSKTNALNV CHHHCCCCCCCCCHH | 37.09 | 23312004 | |
117 | Ubiquitination | LESFNGSKTNALNVS HHHCCCCCCCCCHHH | 47.39 | 21890473 | |
117 (in isoform 1) | Ubiquitination | - | 47.39 | 21890473 | |
118 | Phosphorylation | ESFNGSKTNALNVSQ HHCCCCCCCCCHHHH | 27.67 | 23312004 | |
124 | Phosphorylation | KTNALNVSQKMIEMF CCCCCHHHHHHHHHH | 24.02 | 21406692 | |
126 | Ubiquitination | NALNVSQKMIEMFVR CCCHHHHHHHHHHHH | 34.05 | 21890473 | |
126 (in isoform 1) | Ubiquitination | - | 34.05 | 21890473 | |
194 | Phosphorylation | FSLIQQKTELPVTEN HHHHHHCCCCCCCCC | 38.12 | 22468782 | |
213 | Phosphorylation | PPPYVVRTILVYSRP CCCEEEEEEEEECCC | 13.67 | 22468782 | |
234 | Ubiquitination | SLTEPMKKMFQCPYF CCCHHHHHHHCCCCE | 38.40 | - | |
252 | Phosphorylation | VVYIHNGTEEKEEEM EEEEECCCHHHCHHC | 46.41 | - | |
276 | Phosphorylation | GSLDTKGTSYKYEVA HCCCCCCCCCEEEEE | 30.36 | 30387612 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
29 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BABA1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BABA1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29; SER-49; SER-62;THR-65 AND SER-66, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-49 AND SER-66, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8 AND SER-62, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29, AND MASSSPECTROMETRY. |